Regulatory Challenges
Ann and her team faced significant regulatory hurdles while scaling 23andMe, employing creative workarounds to navigate legal restrictions. When the FDA issued a cease and desist letter, Ann initially underestimated its seriousness, but soon realized the gravity of the situation. Her instinct was to advocate for consumer rights, sparking a pivotal shift in her approach as she grappled with the complexities of regulation and innovation.In this clip
From this podcast
Masters of Scale
23andMe's Anne Wojcicki: Embrace the gatekeepers
Related Questions
Tell me about 23andMe as discussed in the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers and the clip Disruption and Regulation
What is the main topic of the clip Navigating FDA Challenges from the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers?
What is your opinion on 23andMe as discussed in the episode 23andMe's Anne Wojcicki: Embrace the gatekeepers and the clip Direct Access Debate?